IRD
Ticker
Opus Genetics, Inc.
IRD · Healthcare · Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patient…Opus Genetics, Inc. (IRD), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 1 purchase and 6 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Nov 3 and filed Nov 5. The most active filer was Foundation Fighting Blindness Retinal Degeneration Fund with 3 filings. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
7
1 buy · 6 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$19.4M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Nov 3
Filed Nov 5
ADViAverage daily dollar volume
$4.8M
market data
Share price · 12M
$4.18 (+112.2%)
Adjusted for splits and dividends.
Volume by month
Buys $324K
Sells $19.1M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
FF
Foundation Fighting Blindness Retinal Degeneration Fund
Director
3 filings · 0 buys, 3 sales
GM
George Magrath
Chief Executive Officer
2 filings · 0 buys, 2 sales
RG
Robert E. Gagnon
Chief Financial Officer
1 filing · 0 buys, 1 sale
CG
Cam Gallagher
Director
1 filing · 1 buy, 0 sales
Recent filings
George MagrathSALE
Chief Executive Officer
$110K28,258 sh × $3.90
Exec Nov 3
Filed Nov 5 · 4:04 PM ET Foundation Fighting Blindness Retinal Degeneration FundSALE Director $2.8M
556,000 sh × $4.96
Exec Sep 30
Filed Oct 2 · 7:47 PM ET Robert E. GagnonSALE Chief Financial Officer $127K
28,000 sh × $4.54
Exec Sep 3
Filed Sep 8 · 4:05 PM ET Foundation Fighting Blindness Retinal Degeneration FundSALE Director $7.4M
1,700,000 sh × $4.35
Exec May 18
Filed May 20 · 5:30 PM ET George MagrathSALE Chief Executive Officer $127K
24,438 sh × $5.21
Exec Mar 16
Filed Mar 18 · 5:30 PM ET Cam GallagherPURCHASE Director $324K
164,000 sh across 2 lots
Exec Dec 29 2025
Filed Dec 31 2025 · 4:33 PM ET Foundation Fighting Blindness Retinal Degeneration FundSALE Director $8.6M
4,000,000 sh × $2.15
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET